Suscribirse

A smartphone coaching program (“Bouge Grossesse”) improves daily physical activity in pregnant women - 12/09/24

Doi : 10.1016/j.jogoh.2024.102847 
Matthieu MULLER 1, , Pandora JAMES 2  : Resident, Philippe MERVIEL 2, Alain SARAUX 3, Yannick GUILLODO 4 : Director of C2S, Véronique KERLAN 5, Sarah BOUEE 2, Emmanuel NOWAK 6 : biostatistician, Romain MORGANT 7, Emmanuelle Communier-Courtois 8 : biostatistician
1 Department of Gynecology and obstetrics, Hospital Center of Morlaix, France 
2 Department of Gynecology and obstetrics, CHU Brest, France 
3 Department of Rheumatology, CHU Brest, centre de référence maladies rares CERAINO, INSERM UMR 1227, UBO, LabEx IGO, Brest, France 
4 Department of Rheumatology, CHU Brest, France 
5 Department of Endocrinology, CHU Brest, France 
6 Head of Data Management Unit, CHU Brest, France 
7 Trauma practice, TER Clinic, Ploemeur, France 
8 CHRU Brest, France 

Author correspondent: Matthieu MULLER, address: Centre Hospitalier des Pays de Morlaix, 15 rue de Kersaint Gilly, 29600 Morlaix, France, Phone: +33 6 70 45 89 97Centre Hospitalier des Pays de Morlaix, 15 rue de Kersaint GillyMorlaix29600France
En prensa. Manuscrito Aceptado. Disponible en línea desde el Thursday 12 September 2024

Abstract

Background

Physical activity has been shown to reduce obstetrical risks however pregnant women reduce their physical activity and sedentary behaviors increase.

Objective

Our aim was to evaluate the impact of a smartphone application developed to increase daily physical activity in pregnant women.

Methods

We enrolled 250 pregnant women in a prospective randomized controlled study. These women were instructed to download either an intervention application called «Bouge Grossesse» (coaching program and a pedometer; n=125) or a Placebo application (pedometer only; n=125). Primary outcome was defined as a daily increase of 2000 steps/day between day 1 and day 90 or 10 000 steps/week between week 1 and week 12. Data was analyzed with intention to treat. Secondary outcomes were the number of steps at week 12 and the evolution of quality of life measured by WHO score, EIFEL score and SPIEGEL scale, and on maternal and fetal outcomes.

Results

Patients were enrolled between August 2017 and February 2019. They were retrospectively registered after September 2018. We found a significant difference in the primary outcome between the two groups in favor of the intervention group (22.4% success vs 3.2% in the control group, P<.001) but only 43 women in the intervention group (34.4%) and 16 women in the placebo group (12.8%) completed the 12-week coaching program. There were no significant differences in the SPIEGEL, EIFEL and WHO scores. The mean number of daily steps at week 12 was significantly higher in the intervention group (6900.0 vs 4371.9, P<.001).

Conclusion

The mobile health intervention « Bouge Grossesse » significantly increased physical activity in pregnant women but we observed a high percentage of withdrawals from the 12-week program.

Trial registration

This clinical trial was registered under the number NCT03688087 ClinicalTrials.gov.

El texto completo de este artículo está disponible en PDF.

Key words : Physical activity, pregnancy, mHealth, sedentary lifestyles, smartphone application


Esquema


© 2024  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.